Federal award
NOVA BIOMEDICAL CORP
W81K0025CA001
Contract
Obligated and Ceiling
- Obligated (net)
- $335,697.12
- Ceiling (potential value, not spending)
- $843,657.12
- Current value
- $505,017.12
- Gross positive obligations
- $393,596.16
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- NOVA BIOMEDICAL CORP · LCFDHTGXB5J3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- NOVA BIOMEDICAL CORP · LCFDHTGXB5J3
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0025CA001
- Award type code
- D
- Actions
- 7 · Dec 31, 2024 to Mar 12, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 12, 2026 | FY2026 | P00006 | C | −$57,899.04 | — |
| Jan 16, 2026 | FY2026 | P00005 | G | $0.00 | — |
| Dec 17, 2025 | FY2026 | P00004 | C | $169,320.00 | — |
| Dec 15, 2025 | FY2026 | P00003 | M | $0.00 | — |
| May 14, 2025 | FY2025 | P00002 | G | $0.00 | — |
| Jan 17, 2025 | FY2025 | P00001 | M | $0.00 | — |
| Dec 31, 2024 | FY2025 | 0 | — | $224,276.16 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.